Horizon Pharma | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
ALKERMES USD 1.48B 63.7M 2025-03
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bausch Health Companies USD 5.73B 42M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Takeda JPY 2.52T 233.1B 2025-03
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12
Zoetis USD 5.88B 109M 2025-03



Horizon Pharma Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.